The “Ideal” Body Weight for Pediatric Gentamicin Dosing in the Era of Obesity: A Population Pharmacokinetic Analysis
Conclusions:
FFM should be used to adjust ABW for empirically dosing gentamicin in pediatric patients aged 2–18 years.
Source: Therapeutic Drug Monitoring - Category: Drugs & Pharmacology Tags: Original Article Source Type: research
More News: Drugs & Pharmacology | Eating Disorders & Weight Management | Intensive Care | Ireland Health | Obesity | Pediatrics | Statistics | Study